Reducing the risks when using benzodiazepines to treat insomnia: A public health approach

Cleve Clin J Med. 2024 May 1;91(5):293-299. doi: 10.3949/ccjm.91a.23061.

Abstract

Benzodiazepines are widely used but can cause considerable harm, including sedation, addiction, falls, fractures, and cognitive impairment, especially with long-term use and in elderly patients. The authors propose a public health approach to reduce the potential for harm when using benzodiazepines to treat insomnia. Primary prevention involves judicious patient selection and patient education. Secondary prevention requires keeping the duration of use as short as possible according to guidelines. Tertiary prevention, for patients who have been taking a benzodiazepine for a long time, uses shared decision-making to introduce a gradual and carefully monitored taper.

Publication types

  • Review

MeSH terms

  • Benzodiazepines* / adverse effects
  • Benzodiazepines* / therapeutic use
  • Humans
  • Hypnotics and Sedatives / adverse effects
  • Hypnotics and Sedatives / therapeutic use
  • Patient Education as Topic
  • Patient Selection
  • Primary Prevention / methods
  • Public Health
  • Sleep Initiation and Maintenance Disorders* / drug therapy

Substances

  • Benzodiazepines
  • Hypnotics and Sedatives